Answers are grounded in this paper and cite their sources.
Identifies serum phosphatidylcholine markers linked to arsenic-induced hepatic steatosis, suggesting new intervention opportunities.
This study innovatively identifies reduced serum-specific PC molecules as a potential risk marker for arsenic-induced hepatic steatosis. Chkα/Chkβ hypermethylation-mediated PC synthesis disorder is the key mechanism of arsenic-induced hepatic steatosis, and DNMT1, TET1, and TET2 dysregulation may underlie this hypermethylation. PC supplementation or epigenetic correction shows intervention potential.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: